The Histone Deacetylase Inhibitor Vorinostat (SAHA) Increases the Susceptibility of Uninfected CD4+ T Cells to HIV by Increasing the Kinetics and Efficiency of Postentry Viral Events-Reference-Cited by-同舟云学术

The Histone Deacetylase Inhibitor Vorinostat (SAHA) Increases the Susceptibility of Uninfected CD4+ T Cells to HIV by Increasing the Kinetics and Efficiency of Postentry Viral Events

Published:2014-07-09 Issue:18 Volume:88 Page:10803-10812
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:Journal of Virology

Author:

Lucera M. B.,Tilton C. A.,Mao H.,Dobrowolski C.,Tabler C. O.,Haqqani A. A.,Karn J.,Tilton J. C.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference54 articles.

1. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia;Wong;Science,1997

2. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy;Finzi;Science,1997

3. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy;Chun;Proc. Natl. Acad. Sci. U. S. A.,1997

4. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy;Harrigan;AIDS,1999

5. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy;Garcia;AIDS,1999

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoir;mBio;2024-09-11

2. Epigenetic Regulation and Molecular Mechanisms of Burn Injury-Induced Nociception in the Spinal Cord of Mice;International Journal of Molecular Sciences;2024-08-04

3. Structural rearrangements in the nucleus localize latent HIV proviruses to a perinucleolar compartment supportive of reactivation;Proceedings of the National Academy of Sciences;2024-04-26

4. HIV Reservoirs and Treatment Strategies toward Curing HIV Infection;International Journal of Molecular Sciences;2024-02-23

5. CD4+ T cell-targeting immunoliposomes for treatment of latent HIV reservoir;European Journal of Pharmaceutics and Biopharmaceutics;2024-02